EVENT INTELLIGENCE PLATFORM

Outsourcing in Clinical Trials DACH 2025 Attendee List

Explore a sample of the enriched attendee list for Outsourcing in Clinical Trials DACH 2025 to uncover professionals in leadership roles, including exhibitor details, sponsor contacts, and verified email access. This information is sourced via Vendelux, combining organizer-supplied data with predictive insight models.

Maximize Your Impact At Outsourcing in Clinical Trials DACH 2025

Outsourcing in Clinical Trials DACH 2025 brings together senior-level executives and decision-makers from across the life sciences sector, with a strong emphasis on clinical development, outsourcing partnerships, and regulatory planning. This event is a strategic access point for service providers looking to engage with pharmaceutical and biotech companies driving clinical programs across the DACH region.

Attendees typically include VPs and Directors of Clinical Operations, Outsourcing, Procurement, and R&D. These are professionals actively managing multi-million-euro outsourcing budgets, selecting CROs, evaluating new technologies, and forging long-term vendor relationships. Whether you’re offering trial management platforms, decentralized clinical trial support, or compliance-focused services, this forum is an ideal setting for solution-oriented engagement.

Using the enriched attendee list from Vendelux, commercial teams can pinpoint high-value opportunities based on seniority, company size, and involvement in outsourcing. With the right lead intel, your outreach will land in the hands of buyers who are planning their 2026 vendor pipelines before the year ends.

How Sales, Marketing And Revops Teams Can Use This Attendee List

Life sciences sales and marketing teams can use the Outsourcing in Clinical Trials DACH 2025 enriched attendee list to identify decision-makers allocating clinical operations budgets in Q4 and Q1. Segment contacts by title—such as Head of Clinical Outsourcing, Senior Project Manager, or Procurement Director—and match engagement strategies to their outsourcing responsibilities.

Use attendee data to customize outreach aligned with objectives like optimizing trial timelines, ensuring vendor compliance, or increasing oversight visibility. Teams can build meaningful pre-event interactions by prioritizing accounts with active trial portfolios and scheduling conversations focused on 2025-2026 resourcing needs.

This data also makes it easier to secure time during the event with budget owners who can make vendor recommendations or approve trials directly. Use post-event follow-ups to continue conversations around service gaps, sponsor satisfaction, or regional trial execution needs. The enriched conference attendee list helps your sales development team understand who to approach, how to get more meetings, and how to convert in-person conversations into pipeline movement.

Timing Is Everything

Outsourcing in Clinical Trials DACH 2025 will take place from November 12, 2025. With many audience members locking in 2026 outsourcing partnerships by Q4, early engagement is critical.

With Vendelux, commercial teams can use the attendee list to review target accounts, plan strategic outreach campaigns, and confirm meetings before schedules tighten in October. Connecting ahead of the event gives teams a relevant reason to book conversations at a time when clinical buyers are finalizing their vendor matrices for the upcoming year.

What’s Included In The Outsourcing in Clinical Trials DACH 2025 Attendee List?

Vendelux provides visibility into executives expected to attend Outsourcing in Clinical Trials DACH 2025 through a combination of organizer-supplied information and predictive insights. Commercial teams can upload target accounts to find matches within the list and see which of their top prospects are confirmed or expected to attend.

The enriched attendee list includes each contact’s first and last name, job title, company name, company website, city, state, country, LinkedIn profile, verified email address, and phone number where available.

Where Is Outsourcing in Clinical Trials DACH 2025?

The event will be held in Zurich, Zürich, Switzerland. The final venue details are still to be announced.

When Is Outsourcing in Clinical Trials DACH 2025?

The event is scheduled for November 12, 2025.

What Type Of Event Is Outsourcing in Clinical Trials DACH 2025?

Outsourcing in Clinical Trials DACH 2025 is a leading regional event focused on clinical development, vendor management, and regulatory strategy within the DACH life sciences market. The event includes keynote presentations from senior executives, interactive panel discussions, and dedicated networking sessions between sponsors and service providers.

How Many People Attend Outsourcing in Clinical Trials DACH 2025?

The event is expected to attract over 250 attendees, primarily from Germany, Austria, and Switzerland. Attendees are typically senior-level clinical development and outsourcing executives from biotech and pharmaceutical companies.

Unless expressly stated, Vendelux is not endorsed by, affiliated with, authorized by, or in any way officially connected to any event organizer or any of its subsidiaries or affiliates. All product and company names are the registered trademarks of their original owners. The use of any trade name or trademark not owned by Vendelux is for identification and reference purposes only and does not imply any association with such trademark holder.
 
If you are the organizer of this event and wish to provide the complete attendee list for this event to help ensure the accuracy of our data, please contact our Organizer Partnerships team. Submission of attendee information is voluntary and subject to verification. By providing this data, you represent that you have the legal right to share such information and that doing so does not violate any applicable laws, privacy policies, or contractual obligations.
 

Vendelux effortlessly booked over 20 meetings with our core ICP stakeholders across two events - more than triple what we were able to do on our own.

Aaron Bollinger

Chief Revenue Officer (CRO), Voltage

Get the Data